Our website uses cookies. By continuing to browse our site you are agreeing to our Cookie Policy.
Back To Top
In The News

Lonza and Moderna shoot for billion COVID-19 vaccine doses

May 5, 2020
Moderna’s mRNA vaccine candidate for COVID-19 was the first to be administered in humans, after a development time of just 63 days. Read the full article by Ben Hargreaves on wwww.biopharma-reporter.com
block graph showing increase

Related Stories

In The News

NECI Named On CRISPR Therapeutics ISPE FOYA Award, Third FOYA Contribution In Four Years

December 20, 2022
NECI contributed to the CRISPR facility's success by supplying its automation and control systems. This marks the third time in four years that NECI has contributed to a FOYA award-winning facility.
Read More
In The News

Emerson Title Sponsor and Keynote Presenter at Fugitive Emissions Summit Americas 2022

September 7, 2022
This coming September 28 to 29, 2022, the Fugitive Emissions Summit Americas will bring together a community of end users, EPCs, distributors, manufacturers, and suppliers dedicated to improving workplace practices, in efforts to reduce environmental damage caused by industrial emissions.
Read More
In The News

ZÆTHER featured in Boston Business Journal

August 22, 2022
ZÆTHER featured in Boston Business Journal's "Bizspotlight"
Read More